ESSA Pharma Inc.
EPIX
$0.2381
-$0.025-9.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.43M | 3.90M | 4.21M | 3.51M | 3.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.90M | 7.38M | 9.68M | 7.69M | 8.64M |
| Operating Income | -4.90M | -7.38M | -9.68M | -7.69M | -8.64M |
| Income Before Tax | -4.00M | -6.37M | -8.53M | -6.36M | -7.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.00M | -6.37M | -8.53M | -6.36M | -7.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.00M | -6.37M | -8.53M | -6.36M | -7.23M |
| EBIT | -4.90M | -7.38M | -9.68M | -7.69M | -8.64M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.09 | -0.14 | -0.19 | -0.14 | -0.16 |
| Normalized Basic EPS | -0.05 | -0.09 | -0.12 | -0.09 | -0.10 |
| EPS Diluted | -0.09 | -0.14 | -0.19 | -0.14 | -0.16 |
| Normalized Diluted EPS | -0.05 | -0.09 | -0.12 | -0.09 | -0.10 |
| Average Basic Shares Outstanding | 44.39M | 44.39M | 44.39M | 44.37M | 44.37M |
| Average Diluted Shares Outstanding | 44.39M | 44.39M | 44.39M | 44.37M | 44.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |